Pulse Biosciences to Present at the Cantor Global Healthcare Conference
October 01 2018 - 6:18PM
Business Wire
Pulse Biosciences, Inc. (NASDAQ: PLSE), a novel medical therapy
company bringing to market its proprietary Nano-Pulse Stimulation™
platform, announced today that Darrin Uecker, President and
Chief Executive Officer, is scheduled to present at the Cantor
Global Healthcare Conference in New
York at 4:00 p.m. Eastern Time on Wednesday,
October 3rd, 2018.
A live webcast of the presentation will be available through the
Investor Relations pages of the Pulse Biosciences website at
http://investors.pulsebiosciences.com/events-calendar and
at http://wsw.com/webcast/cantor7/plse/. Following the live
presentation, the webcast will be archived and available for replay
at the same address for a period of 90 days.
About Pulse Biosciences
Pulse Biosciences is a novel medical therapy company bringing to
market its proprietary Nano-Pulse Stimulation™ (“NPS™”) platform.
NPS is a novel, precise, non-thermal, treatment technology
delivering nanosecond duration energy pulses that impact cells in
treated tissue while sparing surrounding acellular tissue. NPS’s
unique mechanism of action disrupts the functions of internal cell
structures while maintaining the outer cell membrane initiating a
cascade of events within the cell that results in regulated cell
death. In pre-clinical studies, NPS has demonstrated an ability to
induce immunogenic cell death in cancer cell lines. The novel
characteristics of NPS’s unique mechanism of action has the
potential to significantly benefit patients for multiple medical
applications, including dermatology, the Company’s first planned
commercial application, with future potential in other disease
states where an enhanced immune response may be beneficial. More
information is available at www.pulsebiosciences.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181001006032/en/
Investor Relations:Pulse Biosciences, Inc.Brian DowSr. Vice
President and Chief Financial
OfficerIR@pulsebiosciences.comorSolebury TroutGitanjali Jain Ogawa,
646-378-2949gogawa@troutgroup.comorMedia:Tosk CommunicationsNadine
D. Tosk, 504-453-8344nadinepr@gmail.com
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Apr 2023 to Apr 2024